Brief: MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
27/08/2025 13:06
Aug 27 (Reuters) - MannKind Corp MNKD.O: MANNKIND ANNOUNCES EXPANSION OF UNITED THERAPEUTICS COLLABORATION FOR SECOND INHALED THERAPY Source text: ID:nGNX8bzs9W Further company coverage: MNKD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MannKind
See all newsBrief: MannKind Enters Data-Rich Development Period With Completion Of Randomization In Phase 1B Inflo-1 Study And Enrollment Of First Patient In Phase 2 Inflo-2 Trial For Nintedanib Dpi In Patients With Ipf
U.S. STOCKS ON THE MOVE-Dell, Gap, Costco
MannKind rises after FDA approves inhaled insulin for children
US FDA approves MannKind's inhaled insulin for children (updated)
US FDA approves MannKind's inhaled insulin for children